PTC THERAPEUTICS, INC.
PTCTCIK 0001070081 · Pharmaceutical Preparations · Nasdaq
- PTC THERAPEUTICS INC (until 2005-10-12)
Revenue (TTM)
$1.84B
+114.5% YoY
Q1 May 2026
Net Income (TTM)
$814.8M
+287.9% YoY
Q1 May 2026
EPS Diluted (TTM)
$9.38
+264.5% YoY
Q1 May 2026
Gross Margin
99.4%
Q1 May 2026
Operating Margin
53.5%
Q1 May 2026
Net Margin
44.3%
Q1 May 2026
Free Cash Flow (TTM)
$829.55M
Q1 May 2026
Cash
$833.99M
Q1 May 2026
Total Debt
$572.95M
Q1 May 2026
Shares Outstanding
8.29M sh
Q1 May 2026